Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)
196.20 x 1 201.00 x 1
Post-market by (Cboe BZX)
196.61 -2.10 (-1.06%) 04/21/25 [NYSE]
196.20 x 1 201.00 x 1
Post-market 196.68 +0.07 (+0.04%) 17:54 ET
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
193.82
Day High
198.71
Open 198.71
Previous Close 198.71 198.71
Volume 2,502,000 2,502,000
Avg Vol 2,450,915 2,450,915
Stochastic %K 13.62% 13.62%
Weighted Alpha -20.09 -20.09
5-Day Change -5.17 (-2.56%) -5.17 (-2.56%)
52-Week Range 193.03 - 251.99 193.03 - 251.99
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 57,056,600
  • Shares Outstanding, K 287,135
  • Annual Sales, $ 20,178 M
  • Annual Income, $ 1,705 M
  • EBIT $ 2,414 M
  • EBITDA $ 4,700 M
  • 60-Month Beta 0.35
  • Price/Sales 2.85
  • Price/Cash Flow 9.48
  • Price/Book 2.28

Options Overview Details

View History
  • Implied Volatility 33.57% ( +2.05%)
  • Historical Volatility 30.64%
  • IV Percentile 98%
  • IV Rank 72.48%
  • IV High 40.49% on 04/10/25
  • IV Low 15.34% on 11/26/24
  • Put/Call Vol Ratio 0.32
  • Today's Volume 535
  • Volume Avg (30-Day) 2,505
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 43,152
  • Open Int (30-Day) 48,988

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 3.28
  • Number of Estimates 10
  • High Estimate 3.30
  • Low Estimate 3.22
  • Prior Year 3.17
  • Growth Rate Est. (year over year) +3.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
193.03 +1.85%
on 04/09/25
Period Open: 230.23
231.82 -15.19%
on 03/25/25
-33.62 (-14.60%)
since 03/21/25
3-Month
193.03 +1.85%
on 04/09/25
Period Open: 240.37
251.99 -21.98%
on 02/03/25
-43.76 (-18.21%)
since 01/21/25
52-Week
193.03 +1.85%
on 04/09/25
Period Open: 234.12
251.99 -21.98%
on 02/03/25
-37.51 (-16.02%)
since 04/19/24

Most Recent Stories

More News
Becton, Dickinson and Company’s Quarterly Earnings Preview: What You Need to Know

Becton, Dickinson and Company is set to announce its second-quarter results in the upcoming month, and analysts expect a single-digit growth in earnings.

XLV : 132.57 (-2.16%)
$SPX : 5,158.20 (-2.36%)
BDX : 196.61 (-1.06%)
3 S&P 500 Stocks That Concern Us

3 S&P 500 Stocks That Concern Us

CARR : 58.18 (-2.87%)
BDX : 196.61 (-1.06%)
CLX : 138.64 (-0.82%)
BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

UFPT : 210.63 (-0.20%)
BDX : 196.61 (-1.06%)
TFX : 129.15 (-0.25%)
PODD : 238.57 (-3.33%)
HAE : 57.00 (-0.30%)
3 of Wall Street’s Favorite Stocks Skating on Thin Ice

3 of Wall Street’s Favorite Stocks Skating on Thin Ice

BDX : 196.61 (-1.06%)
BSY : 42.41 (-1.81%)
DOCU : 71.89 (-4.68%)
All the Stocks Warren Buffett Bought in the Last 2 Recessions: Are They Smart Picks Now?

The U.S. economy is "perilously close to slipping into recession" because of President Donald Trump's tariffs, according to JPMorgan Chase chief economist Michael Feroli. Should investors worry? I can...

GOLD : 20.45 (+1.39%)
UAL : 65.30 (-1.51%)
NRG : 93.09 (-4.87%)
PNC : 150.13 (-1.44%)
IRM : 81.61 (-3.09%)
JPM : 228.99 (-1.28%)
BRK.A : 760,489.00 (-2.36%)
JNJ : 156.92 (-0.35%)
KHC : 29.94 (+1.63%)
BRK.B : 506.92 (-2.18%)
BRK.TO : 37.89 (-2.29%)
UNH : 425.33 (-6.34%)
Surgical Equipment & Consumables - Diversified Stocks Q4 Recap: Benchmarking STERIS (NYSE:STE)

Surgical Equipment & Consumables - Diversified Stocks Q4 Recap: Benchmarking STERIS (NYSE:STE)

SOLV : 63.94 (-3.50%)
ZBH : 96.17 (-1.79%)
STE : 218.78 (-1.55%)
BDX : 196.61 (-1.06%)
CNMD : 47.66 (-1.91%)
BDX Stock Declines Following Class I Classification for Alaris Recall

Becton, Dickinson and Company’s BDX, or popularly known as BD, initiated the recall of its infusion pumps last month after customer reports indicated software issues, potentially leading to inaccurate...

BSX : 93.58 (-1.62%)
BDX : 196.61 (-1.06%)
COR : 281.16 (-1.95%)
CAH : 131.17 (-2.63%)
Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)

Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)

SOLV : 63.94 (-3.50%)
ZBH : 96.17 (-1.79%)
STE : 218.78 (-1.55%)
BDX : 196.61 (-1.06%)
CNMD : 47.66 (-1.91%)
Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks

Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks

SOLV : 63.94 (-3.50%)
ZBH : 96.17 (-1.79%)
STE : 218.78 (-1.55%)
BDX : 196.61 (-1.06%)
CNMD : 47.66 (-1.91%)
Becton, Dickinson, and Company Stock: Is BDX Underperforming the Healthcare Sector?

Becton, Dickinson and Company has lagged behind the broader healthcare sector recently, yet Wall Street analysts remain highly optimistic about its future growth potential.

XLV : 132.57 (-2.16%)
BDX : 196.61 (-1.06%)
BAX : 28.54 (-1.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational...

See More

Key Turning Points

3rd Resistance Point 203.83
2nd Resistance Point 201.27
1st Resistance Point 198.94
Last Price 196.61
1st Support Level 194.05
2nd Support Level 191.49
3rd Support Level 189.16

See More

52-Week High 251.99
Fibonacci 61.8% 229.46
Fibonacci 50% 222.51
Fibonacci 38.2% 215.55
Last Price 196.61
52-Week Low 193.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro